Search results
Results From The WOW.Com Content Network
By 2015 the annual price of Kalydeco had been increased to more than $300,000 per patient. According to an article published in the Milwaukee Journal Sentinel Vertex executives "grossed more than $100 million by cashing in stocks and stock options" and at "one point, the value of company's stock increased more $6 billion in a single day."
Despite Vertex's strong gains over the past few years, this can still be an excellent stock to buy right now. Trading at a price/earnings-to-growth ratio, or PEG, of just 0.6, Vertex may even turn ...
The S&P 500 is a stock market index maintained by S&P Dow Jones Indices. It comprises 503 common stocks which are issued by 500 large-cap companies traded on American stock exchanges (including the 30 companies that compose the Dow Jones Industrial Average). The index includes about 80 percent of the American equity market by capitalization.
Vertex was founded in 1978 by Ray Westphal. Jeff Westphal, Stevie Westphal Thompson and Amanda Westphal Radcliffe purchased interest in the company from their father in 2000. [1] On July 29, 2020, the company went public on the Nasdaq stock exchange.
For premium support please call: 800-290-4726 more ways to reach us
With its stock down 5.8% over the past week, it is easy to disregard Vertex Pharmaceuticals (NASDAQ:VRTX). However...
Vertex Pharmaceuticals (NASDAQ:VRTX) has had a rough three months with its share price down 3.4%. But if you pay close...
Vertex Venture Holdings, also known as Vertex Holdings, is an investment holding company with a group of venture capital funds worldwide. A subsidiary of Temasek Holdings, the company focuses on venture capital investment opportunities in the information technology and healthcare markets through its global family of six direct investment ...